M.D. Anderson's C. Stratton Hill Receives Award From American Cancer Society

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 23 No 5
Volume 23
Issue 5

CHICAGO--The American Cancer Society has presented its Humanitarian Award to C. Stratton Hill, Jr., MD, of the University of Texas M.D. Anderson Cancer Center. The award is given for dedication to thea improvement of cancer control and genuine accomplishment in human welfare.

CHICAGO--The American Cancer Society has presented its HumanitarianAward to C. Stratton Hill, Jr., MD, of the University of TexasM.D. Anderson Cancer Center. The award is given for dedicationto thea improvement of cancer control and genuine accomplishmentin human welfare.

As an oncologic endocrinologist, and later as associate directorof clinics at M.D. Anderson, Dr. Hill helped lay the foundationfor what has become the largest oncologic clinic in the world.As director of the Pain Service at M.D. Anderson, Dr. Hill hasworked to improve the state of pain control and has earned aninternational reputation as a leader in this field, working withstate legislatures and pharmacy and narcotic boards.

Recent Videos
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content